New diabetes clinical trial: SGLT2 Inhibitors and Reducing the Risk of Cancers Among Diabetics , an Observational Study

Published on: November 10, 2022 at 11:00AM
Conditions:   Cancer;   Diabetes Mellitus, Type 2;   Interleukin 6;   SGLT2 Inhibitors
Intervention:   Diagnostic Test: interleukin 6
Sponsor:   Ministry of Health, Saudi Arabia
Enrolling by invitation
https://ift.tt/DlxaZ10